Search results
Editas Medicine (NASDAQ:EDIT) investors are sitting on a loss of 90% if they invested three years...
Simply Wall St. via Yahoo Singapore Finance· 2 weeks agoIt's not possible to invest over long periods without making some bad investments. But you want to...
Is Editas Medicine, Inc. (EDIT) One of the Best Biotech Penny Stocks to Buy Now?
Insider Monkey via Yahoo Singapore Finance· 3 weeks agoWe recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we are...
What Makes Editas Medicine, Inc. (EDIT) One of the Best Small-Cap Stocks with Highest Upside...
Insider Monkey via Yahoo Singapore Finance· 3 weeks agoWe recently compiled a list of the Top 10 Small-Cap Stocks with Highest Upside Potential. In this...
Editas (EDIT) Reports Upbeat New Data From Reni-Cel Studies
Zacks via Yahoo Singapore Finance· 1 month agoEditas (EDIT) reports positive new safety and efficacy data from the RUBY and EdiTHAL studies...
EVP, Chief Financial Officer Erick Lucera Sells 22,337 Shares of Editas Medicine Inc
GuruFocus.com via Yahoo Singapore Finance· 2 months agoErick Lucera, the EVP, Chief Financial Officer of Editas Medicine Inc (NASDAQ:EDIT), sold 22,337...
Director Jessica Hopfield Acquires 45,000 Shares of Editas Medicine Inc
GuruFocus.com via Yahoo Singapore Finance· 2 months agoOn May 13, 2024, Jessica Hopfield, Director at Editas Medicine Inc (NASDAQ:EDIT), purchased 45,000...
Editas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Singapore Finance· 2 months agoEditas Medicine, Inc. (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript May 8, 2024 Editas Medicine,...
Editas (EDIT) Down 2.3% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Singapore Finance· 1 month agoIt has been about a month since the last earnings report for Editas Medicine (EDIT). Shares have...
Editas Medicine (EDIT) Crossed Above the 20-Day Moving Average: What That Means for Investors
Zacks via Yahoo Singapore Finance· 1 year agoEditas Medicine (EDIT) reached a significant support level, and could be a good pick for investors...
Editas Medicine, Inc. (NASDAQ:EDIT) Consensus Forecasts Have Become A Little Darker Since Its Latest...
Simply Wall St. via Yahoo Singapore Finance· 2 months agoEditas Medicine, Inc. (NASDAQ:EDIT) just released its latest quarterly report and things are not...